Literature DB >> 24196454

Dendritic cells in atherosclerosis.

Manikandan Subramanian1, Ira Tabas.   

Abstract

Atherosclerosis is a chronic inflammatory disease with activation of both the innate and adaptive arms of the immune system. Dendritic cells (DCs) are potent activators of adaptive immunity and have been identified in the normal arterial wall and within atherosclerotic lesions. Recent evidence points to a functional role for DCs in all stages of atherosclerosis because of their myriad functions including lipid uptake, antigen presentation, efferocytosis, and inflammation resolution. Moreover, DC-based vaccination strategies are currently being developed for the treatment of atherosclerosis. This review will focus on the current evidence as well as the proposed roles for DCs in the pathogenesis of atherosclerosis and discuss future therapeutic strategies.

Entities:  

Mesh：

Year:  2013        PMID： 24196454      PMCID： PMC3946524          DOI： 10.1007/s00281-013-0400-x

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN： 1863-2297            Impact factor:   9.623


  72 in total

Review 1.  Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.

Authors:  Ira Tabas; Kevin Jon Williams; Jan Borén
Journal:  Circulation       Date:  2007-10-16       Impact factor: 29.690

Review 2.  Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Authors:  Hélène Bour-Jordan; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

3.  oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation.

Authors:  Thomas Nickel; Daniel Schmauss; Henner Hanssen; Zelka Sicic; Bjarne Krebs; Sarika Jankl; Claudia Summo; Peter Fraunberger; Autar K Walli; Susanne Pfeiler; Michael Weis
Journal:  Atherosclerosis       Date:  2009-01-09       Impact factor: 5.162

4.  Induction of dendritic cell-like phenotype in macrophages during foam cell formation.

Authors:  Hyung Jun Cho; Pavel Shashkin; Christian A Gleissner; Dane Dunson; Nitin Jain; Jae K Lee; Yury Miller; Klaus Ley
Journal:  Physiol Genomics       Date:  2007-01-23       Impact factor: 3.107

5.  'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells.

Authors:  R Zaguri; I Verbovetski; M Atallah; U Trahtemberg; A Krispin; E Nahari; E Leitersdorf; D Mevorach
Journal:  Clin Exp Immunol       Date:  2007-07-23       Impact factor: 4.330

6.  Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.

Authors:  Heather M Seitz; Todd D Camenisch; Greg Lemke; H Shelton Earp; Glenn K Matsushima
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

7.  Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.

Authors:  Hafid Ait-Oufella; Kiyoka Kinugawa; Joffrey Zoll; Tabassome Simon; Jacques Boddaert; Silvia Heeneman; Olivier Blanc-Brude; Véronique Barateau; Stéphane Potteaux; Régine Merval; Bruno Esposito; Elisabeth Teissier; Mat J Daemen; Guy Lesèche; Chantal Boulanger; Alain Tedgui; Ziad Mallat
Journal:  Circulation       Date:  2007-04-09       Impact factor: 29.690

Review 8.  Vaccination against atherosclerosis? Induction of atheroprotective immunity.

Authors:  Göran K Hansson; Jan Nilsson
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

9.  Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque.

Authors:  Alexander Niessner; Min Sun Shin; Olga Pryshchep; Jörg J Goronzy; Elliot L Chaikof; Cornelia M Weyand
Journal:  Circulation       Date:  2007-10-15       Impact factor: 29.690

10.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.

Authors:  Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie
Journal:  J Exp Med       Date:  2007-07-09       Impact factor: 14.307
View more
  22 in total

Review 1.  Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.

Authors:  Daniel F J Ketelhuth; Esther Lutgens; Magnus Bäck; Christoph J Binder; Jan Van den Bossche; Carolin Daniel; Ingrid E Dumitriu; Imo Hoefer; Peter Libby; Luke O'Neill; Christian Weber; Paul C Evans
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

2.  Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.

Authors:  Shuang Chen; Kenichi Shimada; Timothy R Crother; Ebru Erbay; Prediman K Shah; Moshe Arditi
Journal:  J Am Coll Cardiol       Date:  2018-04-10       Impact factor: 24.094

3.  Monocyte-Derived Dendritic Cells Upregulate Extracellular Catabolism of Aggregated Low-Density Lipoprotein on Maturation, Leading to Foam Cell Formation.

Authors:  Abigail S Haka; Rajesh K Singh; Inna Grosheva; Haley Hoffner; Estibaliz Capetillo-Zarate; Harvey F Chin; Niroshana Anandasabapathy; Frederick R Maxfield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-20       Impact factor: 8.311

4.  Identification of a non-growth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling.

Authors:  Manikandan Subramanian; Edward Thorp; Ira Tabas
Journal:  Circ Res       Date:  2014-10-27       Impact factor: 17.367

5.  Anti-atherogenic peptide Ep1.B derived from apolipoprotein E induces tolerogenic plasmacytoid dendritic cells.

Authors:  S M Bellemore; E Nikoopour; B C Y Au; O Krougly; E Lee-Chan; S M Haeryfar; B Singh
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

6.  Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis.

Authors:  Renée J H A Tillie; Jenny De Bruijn; Javier Perales-Patón; Lieve Temmerman; Yanal Ghosheh; Kim Van Kuijk; Marion J Gijbels; Peter Carmeliet; Klaus Ley; Julio Saez-Rodriguez; Judith C Sluimer
Journal:  Front Cell Dev Biol       Date:  2021-08-12

7.  SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.

Authors:  Sergiy Sukhanov; Yusuke Higashi; Shaw-Yung Shai; Patricia Snarski; Svitlana Danchuk; Veronica D'Ambra; Michael Tabony; T Cooper Woods; Xuwei Hou; Zhaohui Li; Atsufumi Ozoe; Bysani Chandrasekar; Shin-Ichiro Takahashi; Patrice Delafontaine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 8.  The role of high-density lipoprotein in the regulation of the immune response: implications for atherosclerosis and autoimmunity.

Authors:  Marisa Fernandes das Neves; Joana R Batuca; José Delgado Alves
Journal:  Immunology       Date:  2021-05-22       Impact factor: 7.215

Review 9.  Dendritic cells in atherosclerotic inflammation: the complexity of functions and the peculiarities of pathophysiological effects.

Authors:  Dimitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Front Physiol       Date:  2014-05-27       Impact factor: 4.566

Review 10.  A myriad of roles of dendritic cells in atherosclerosis.

Authors:  Yanfang Zhao; Jing Zhang; Wenjie Zhang; Yuekang Xu
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 5.732
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.